W. Takada

Structure-activity relationships of an anti-HIV peptide, T22.

A. Otaka, H. Tamamura, M. Waki, 1994, Biochemical and biophysical research communications.

Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity.

A. Otaka, H. Tamamura, M. Waki, 1995, Chemical & pharmaceutical bulletin.

Chem. Pharm. Bull. 53(2) 172—176 (2005)

M. Mifune, Yutaka Saito, W. Takada, 2005 .

A straightforward protocol for the preparation of high performance microarray displaying synthetic MUC1 glycopeptides.

S. Nishimura, Takahiko Matsushita, H. Hinou, 2014, Biochimica et biophysica acta.

Quantitative determination method for trace amount of penicillin contaminants in commercially available drug product by HPLC coupled with tandem mass spectrometry.

M. Mifune, Yutaka Saito, W. Takada, 2005, Chemical & pharmaceutical bulletin.

Synthetic glycopeptides reveal specific binding pattern and conformational change at O-mannosylated position of α-dystroglycan by POMGnT1 catalyzed GlcNAc modification.

S. Nishimura, H. Hinou, W. Takada, 2019, Bioorganic & medicinal chemistry.

A sulfated glycosaminoglycan array for molecular interactions between glycosaminoglycans and growth factors or anti-glycosaminoglycan antibodies.

P. Kongtawelert, P. Pothacharoen, W. Takada, 2013, Analytical biochemistry.

Solution-phase synthesis of an anti-human immunodeficiency virus peptide, T22 ([Tyr5,12,Lys7]-polyphemusin II), and the modification of Trp by the p-methoxybenzyl group of Cys during trimethylsilyl trifluoromethanesulfonate deprotection.

A. Otaka, H. Tamamura, H. Yoshizawa, 1995, Chemical & pharmaceutical bulletin.